Skip to main content

Considerations for the use of real-world data and real-world evidence to support regulatory decision-making for drug and biological products - guidance for industry

Draft guidance

We have adopted this International Scientific Guideline.

Last updated

Help us improve the Therapeutic Goods Administration site